Showing results (521-530 of 544) with videos related to

Sort By:
Pageof 55
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2025
Efficacy and Safety of HSK31679 in Asian Patients with MASLD: A Randomized Controlled TrialFeng Xue, Wei Ma, Jixian Gao, et al.
Eclinicalmedicine|May 17, 2024
Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trialJie Wang, Yuehui Yin, Chengzhi Lu, et al.
Clinical Cardiology|October 15, 2021
Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study IIYanjun Gong, Xuan Li, Xiang Ma, et al.
European Journal of Preventive Cardiology|August 29, 2025
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIREJaimini Cegla, Catriona Jennings, Eanna Kenny, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 8, 2020
[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)]Jun Bu, Mao Chen, Xiaoshu Cheng, et al.
European Heart Journal|August 30, 2024
Variation in secondary prevention of coronary heart disease: the INTERASPIRE studyJohn William McEvoy, Catriona Jennings, Kornelia Kotseva, et al.
European Journal of Cardiovascular Nursing|August 29, 2025
Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regionsCatriona Sian Jennings, Eanna Kenny, Dirk De Bacquer, et al.
American Journal of Preventive Cardiology|July 3, 2026
Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE studyChathurangani Menaka Balasooriya, Catriona Jennings, Eanna Kenny, et al.
European Journal of Preventive Cardiology|August 12, 2025
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE studyJulia Brandts, Fotios Barkas, Dirk De Bacquer, et al.
European Journal of Preventive Cardiology|November 13, 2025
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE studyChantal F Ski, Catriona S Jennings, Dirk De Bacquer, et al.
Pageof 55